Replies to post #327684 on Amarin Corp Plc (AMRN)

[HDGabor]

K- (& studythosestocks #327693)

I expect the PPS to rally and Dr Reddy to rethink entering the market.

Why? What will be the Order? What will limit Dr. Reddy to enter?

- - - - -
studythosestocks #327693

If they win the lawsuit then Hikma not any of the generics can sell their product outside of the high trigs >500 indication
This means we lose only 10% or less of the US market

Hikma or any of the generics can sell their product for he high trigs >500 indication only already ... Do you expect the 10% lose only? Do you expect no generic will be dispensed outside of the high trigs >500 indication? ... Will not the direct infringement exist due to lack of inducement?

This increases scripts, lower tiers since there is no generic equivalent.

? No generic for R-IT indication ... Do you expect that gV will be dropped from Tier 1?

Best,
G

[eightisenough]

kiwi--you're 100% correct. Other generics will not try to compete even in the over 500 trig market b/b it is not worth the investment for an insubstantial profit/market.

The other generics will not enter b/c even if they are smarter than Hickma's management and don't make infringement statements--they cannot remove the cardio limitation (b/c that is induced infringement), and if they leave in the limitation then their product is not useable for cardiac benefit under 500 trigs.

8